Increased Circulating and Urinary Levels of Soluble TAM Receptors in Diabetic Nephropathy

TAM receptors (Tyro3, Axl, and Mer) have been implicated in innate immunity. Circulating TAM receptor soluble forms (sTyro3, sAxl, sMer) are related to autoimmune disorders. We investigated TAM and their ligand protein S in patients with diabetes. Urinary and plasma levels of protein S, sTyro3, sAxl...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:The American journal of pathology Ročník 187; číslo 9; s. 1971
Hlavní autoři: Ochodnicky, Peter, Lattenist, Lionel, Ahdi, Mohamed, Kers, Jesper, Uil, Melissa, Claessen, Nike, Leemans, Jaklien C, Florquin, Sandrine, Meijers, Joost C M, Gerdes, Victor E A, Roelofs, Joris J T H
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.09.2017
Témata:
ISSN:1525-2191, 1525-2191
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract TAM receptors (Tyro3, Axl, and Mer) have been implicated in innate immunity. Circulating TAM receptor soluble forms (sTyro3, sAxl, sMer) are related to autoimmune disorders. We investigated TAM and their ligand protein S in patients with diabetes. Urinary and plasma levels of protein S, sTyro3, sAxl, and sMer were determined in 126 patients with diabetes assigned to a normoalbuminuric or macroalbuminuric (urinary albumin excretion <30 mg/24 hours and >300 mg/24 hours, respectively) study group and 18 healthy volunteers. TAM and protein S immunostaining was performed on kidney biopsy specimens from patients with diabetic nephropathy (n = 9) and controls (n = 6). TAM expression and shedding by tubular epithelial cells were investigated by PCR and enzyme-linked immunosorbent assay in an in vitro diabetes model. Patients with macroalbuminuria diabetes had higher circulating levels of sMer and more urinary sTyro3 and sMer than normoalbuminuric diabetics. Increased clearance of sTyro3 and sMer was associated with loss of tubular Tyro3 and Mer expression in diabetic nephropathy tissue and glomerular depositions of protein S. During in vitro diabetes, human kidney cells had down-regulation of Tyro3 and Mer mRNA and increased shedding of sTyro3 and sMer. Renal injury in diabetes is associated with elevated systemic and urine levels of sMer and sTyro3. This is the first study reporting excretion of sTAM receptors in urine, identifying the kidney as a source of sTAM.
AbstractList TAM receptors (Tyro3, Axl, and Mer) have been implicated in innate immunity. Circulating TAM receptor soluble forms (sTyro3, sAxl, sMer) are related to autoimmune disorders. We investigated TAM and their ligand protein S in patients with diabetes. Urinary and plasma levels of protein S, sTyro3, sAxl, and sMer were determined in 126 patients with diabetes assigned to a normoalbuminuric or macroalbuminuric (urinary albumin excretion <30 mg/24 hours and >300 mg/24 hours, respectively) study group and 18 healthy volunteers. TAM and protein S immunostaining was performed on kidney biopsy specimens from patients with diabetic nephropathy (n = 9) and controls (n = 6). TAM expression and shedding by tubular epithelial cells were investigated by PCR and enzyme-linked immunosorbent assay in an in vitro diabetes model. Patients with macroalbuminuria diabetes had higher circulating levels of sMer and more urinary sTyro3 and sMer than normoalbuminuric diabetics. Increased clearance of sTyro3 and sMer was associated with loss of tubular Tyro3 and Mer expression in diabetic nephropathy tissue and glomerular depositions of protein S. During in vitro diabetes, human kidney cells had down-regulation of Tyro3 and Mer mRNA and increased shedding of sTyro3 and sMer. Renal injury in diabetes is associated with elevated systemic and urine levels of sMer and sTyro3. This is the first study reporting excretion of sTAM receptors in urine, identifying the kidney as a source of sTAM.TAM receptors (Tyro3, Axl, and Mer) have been implicated in innate immunity. Circulating TAM receptor soluble forms (sTyro3, sAxl, sMer) are related to autoimmune disorders. We investigated TAM and their ligand protein S in patients with diabetes. Urinary and plasma levels of protein S, sTyro3, sAxl, and sMer were determined in 126 patients with diabetes assigned to a normoalbuminuric or macroalbuminuric (urinary albumin excretion <30 mg/24 hours and >300 mg/24 hours, respectively) study group and 18 healthy volunteers. TAM and protein S immunostaining was performed on kidney biopsy specimens from patients with diabetic nephropathy (n = 9) and controls (n = 6). TAM expression and shedding by tubular epithelial cells were investigated by PCR and enzyme-linked immunosorbent assay in an in vitro diabetes model. Patients with macroalbuminuria diabetes had higher circulating levels of sMer and more urinary sTyro3 and sMer than normoalbuminuric diabetics. Increased clearance of sTyro3 and sMer was associated with loss of tubular Tyro3 and Mer expression in diabetic nephropathy tissue and glomerular depositions of protein S. During in vitro diabetes, human kidney cells had down-regulation of Tyro3 and Mer mRNA and increased shedding of sTyro3 and sMer. Renal injury in diabetes is associated with elevated systemic and urine levels of sMer and sTyro3. This is the first study reporting excretion of sTAM receptors in urine, identifying the kidney as a source of sTAM.
TAM receptors (Tyro3, Axl, and Mer) have been implicated in innate immunity. Circulating TAM receptor soluble forms (sTyro3, sAxl, sMer) are related to autoimmune disorders. We investigated TAM and their ligand protein S in patients with diabetes. Urinary and plasma levels of protein S, sTyro3, sAxl, and sMer were determined in 126 patients with diabetes assigned to a normoalbuminuric or macroalbuminuric (urinary albumin excretion <30 mg/24 hours and >300 mg/24 hours, respectively) study group and 18 healthy volunteers. TAM and protein S immunostaining was performed on kidney biopsy specimens from patients with diabetic nephropathy (n = 9) and controls (n = 6). TAM expression and shedding by tubular epithelial cells were investigated by PCR and enzyme-linked immunosorbent assay in an in vitro diabetes model. Patients with macroalbuminuria diabetes had higher circulating levels of sMer and more urinary sTyro3 and sMer than normoalbuminuric diabetics. Increased clearance of sTyro3 and sMer was associated with loss of tubular Tyro3 and Mer expression in diabetic nephropathy tissue and glomerular depositions of protein S. During in vitro diabetes, human kidney cells had down-regulation of Tyro3 and Mer mRNA and increased shedding of sTyro3 and sMer. Renal injury in diabetes is associated with elevated systemic and urine levels of sMer and sTyro3. This is the first study reporting excretion of sTAM receptors in urine, identifying the kidney as a source of sTAM.
Author Leemans, Jaklien C
Claessen, Nike
Roelofs, Joris J T H
Lattenist, Lionel
Uil, Melissa
Florquin, Sandrine
Kers, Jesper
Gerdes, Victor E A
Ochodnicky, Peter
Meijers, Joost C M
Ahdi, Mohamed
Author_xml – sequence: 1
  givenname: Peter
  surname: Ochodnicky
  fullname: Ochodnicky, Peter
  organization: Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 2
  givenname: Lionel
  surname: Lattenist
  fullname: Lattenist, Lionel
  organization: Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 3
  givenname: Mohamed
  surname: Ahdi
  fullname: Ahdi, Mohamed
  organization: Department of Internal Medicine, Slotervaart Hospital, Amsterdam, the Netherlands
– sequence: 4
  givenname: Jesper
  surname: Kers
  fullname: Kers, Jesper
  organization: Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 5
  givenname: Melissa
  surname: Uil
  fullname: Uil, Melissa
  organization: Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 6
  givenname: Nike
  surname: Claessen
  fullname: Claessen, Nike
  organization: Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 7
  givenname: Jaklien C
  surname: Leemans
  fullname: Leemans, Jaklien C
  organization: Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 8
  givenname: Sandrine
  surname: Florquin
  fullname: Florquin, Sandrine
  organization: Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Department of Pathology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands
– sequence: 9
  givenname: Joost C M
  surname: Meijers
  fullname: Meijers, Joost C M
  organization: Department of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Department of Plasma Proteins, Sanquin Research, Amsterdam, the Netherlands
– sequence: 10
  givenname: Victor E A
  surname: Gerdes
  fullname: Gerdes, Victor E A
  organization: Department of Internal Medicine, Slotervaart Hospital, Amsterdam, the Netherlands; Department of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
– sequence: 11
  givenname: Joris J T H
  surname: Roelofs
  fullname: Roelofs, Joris J T H
  email: j.j.roelofs@amc.nl
  organization: Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: j.j.roelofs@amc.nl
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28668213$$D View this record in MEDLINE/PubMed
BookMark eNpNkMtOwzAURC1URB_wBwh5ySbB147TZFmVV6UCErQLVpHj3FBXrhPsBKl_TxFFYjWzGI3mzJgMXOOQkEtgMTBIb7ax2raq28ScwTRmMmYsOSEjkFxGHHIY_PNDMg5hyxhLRcbOyJBnaZpxECPyvnDaowpY0bnxureqM-6DKlfRtTdO-T1d4hfaQJuavjW2Ly3S1eyJvqLGtmt8oMbRW6NK7Iymz9hufPMza39OTmtlA14cdULW93er-WO0fHlYzGfLCEUqu0hDlSCqhMmy1pkQNWrQUuVa1kKKJElYKZTIEwQ5TWulVQqgYCo4SJ2VAHxCrn97W9989hi6YmeCRmuVw6YPxQFfSpllOT9Er47RvtxhVbTe7A6Exd8d_BuP2WVF
ContentType Journal Article
Copyright Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.ajpath.2017.05.004
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1525-2191
ExternalDocumentID 28668213
Genre Journal Article
GroupedDBID ---
--K
-~X
.1-
.55
.FO
.GJ
0R~
1P~
23M
2WC
34R
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
6J9
7-5
7X7
88E
88I
8AF
8C1
8FE
8FH
8FI
8FJ
8R4
8R5
AACTN
AAEDT
AAEDW
AAIKJ
AALRI
AAQFI
AAQXK
AAXUO
ABCQX
ABJNI
ABLJU
ABMAC
ABOCM
ABUWG
ABWVN
ACGFO
ACGOD
ACPRK
ACRPL
ADBBV
ADEZE
ADHJS
ADMUD
ADNMO
ADVLN
AENEX
AEVXI
AFCTW
AFFNX
AFJKZ
AFKRA
AFRHN
AFTJW
AGHFR
AHDRD
AHMBA
AI.
AITUG
AJUYK
AKRWK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AZFZN
AZQEC
BAWUL
BBNVY
BELOY
BENPR
BHPHI
BPHCQ
BVXVI
C1A
CCPQU
CGR
CS3
CUY
CVF
DIK
DWQXO
E3Z
EBS
ECM
EFJIC
EIF
EJD
F5P
FDB
FEDTE
FGOYB
FYUFA
GBLVA
GNUQQ
GX1
H13
HCIFZ
HMCUK
HVGLF
HX~
HZ~
IH2
IXB
J5H
KOM
KQ8
L7B
LID
LK8
M1P
M2P
M41
M7P
MVM
N9A
NPM
O9-
OG~
OHT
OK1
OS.
P2P
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
R2-
ROL
RPM
SEL
SES
SJN
SSZ
TIP
TR2
UKHRP
VH1
WH7
WOQ
X7M
XH2
Y6R
YHG
YNH
Z5R
ZGI
ZXP
7X8
AAFWJ
ACVFH
ADCNI
AEUPX
AFPUW
AIGII
AKBMS
AKYEP
EFKBS
ID FETCH-LOGICAL-e365t-c1d4eea405bfc833fec1c5a9c5f3534440b3a394e1576faca611a173215c8b112
IEDL.DBID 7X8
ISICitedReferencesCount 20
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000409158900007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1525-2191
IngestDate Sat Sep 27 18:14:19 EDT 2025
Thu Apr 03 06:59:06 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-e365t-c1d4eea405bfc833fec1c5a9c5f3534440b3a394e1576faca611a173215c8b112
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.clinicalkey.com/#!/content/1-s2.0-S0002944017300548
PMID 28668213
PQID 1915558892
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1915558892
pubmed_primary_28668213
PublicationCentury 2000
PublicationDate 2017-Sep
20170901
PublicationDateYYYYMMDD 2017-09-01
PublicationDate_xml – month: 09
  year: 2017
  text: 2017-Sep
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The American journal of pathology
PublicationTitleAlternate Am J Pathol
PublicationYear 2017
SSID ssj0006380
Score 2.3506896
Snippet TAM receptors (Tyro3, Axl, and Mer) have been implicated in innate immunity. Circulating TAM receptor soluble forms (sTyro3, sAxl, sMer) are related to...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1971
SubjectTerms Adult
Aged
Aged, 80 and over
c-Mer Tyrosine Kinase
Cell Line
Diabetic Nephropathies - blood
Diabetic Nephropathies - metabolism
Diabetic Nephropathies - urine
Female
Humans
Kidney Glomerulus - metabolism
Male
Middle Aged
Protein S - metabolism
Protein S - urine
Proto-Oncogene Proteins - blood
Proto-Oncogene Proteins - metabolism
Proto-Oncogene Proteins - urine
Receptor Protein-Tyrosine Kinases - blood
Receptor Protein-Tyrosine Kinases - metabolism
Receptor Protein-Tyrosine Kinases - urine
Title Increased Circulating and Urinary Levels of Soluble TAM Receptors in Diabetic Nephropathy
URI https://www.ncbi.nlm.nih.gov/pubmed/28668213
https://www.proquest.com/docview/1915558892
Volume 187
WOSCitedRecordID wos000409158900007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JSwMxFA5qRby4L3Ujgtdgs81MTlLE4qEtPbRQTyWTvEhFpmNbBf-9SWZKT4LgZW4Dk5e3fPPy5X0I3VlfR3OVtohUWhIhGRClmSVK6NxCC3xZiTvdTfv9bDxWg7rhtqhplaucGBO1nZnQI7-nYZC5zDLFHsoPElSjwulqLaGxiRrcQ5lA6UrH62nh3rfihUjJJPGRSVdX5yK_S78Fzd9A7qpmd0aptl9AZiw2nf3_fuYB2qthJm5XfnGINqA4Qju9-iD9GL34vBDo6GDx43RuooZX8Yp1YfFoHq_o4m6gEy3wzOHQOsvfAQ_bPexhJpRBoQdPC1zRaaYG96EMcgt-pd8naNR5Gj4-k1plgQBP5JIYagWA9sAtdybj3IGhRmplpOOSCyFaOddcCaD-18RpoxNKNU25xwomyz1cO0VbxayAc4Qdc8wmmRaOgRCpUdb4GIc8tUbkiW010e3KaBPvxeFoQhcw-1xM1mZrorPK8pOyGrcxYVmSZIzyiz-8fYl2w4ZWJLAr1HA-huEabZuv5XQxv4nu4Z_9Qe8HDS7E4Q
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+Circulating+and+Urinary+Levels+of+Soluble+TAM+Receptors+in+Diabetic+Nephropathy&rft.jtitle=The+American+journal+of+pathology&rft.au=Ochodnicky%2C+Peter&rft.au=Lattenist%2C+Lionel&rft.au=Ahdi%2C+Mohamed&rft.au=Kers%2C+Jesper&rft.date=2017-09-01&rft.eissn=1525-2191&rft.volume=187&rft.issue=9&rft.spage=1971&rft_id=info:doi/10.1016%2Fj.ajpath.2017.05.004&rft_id=info%3Apmid%2F28668213&rft_id=info%3Apmid%2F28668213&rft.externalDocID=28668213
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1525-2191&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1525-2191&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1525-2191&client=summon